We are live on
!
Find out more
SEI Investments Portfolio holdings
AUM
$108B
1-Year Est. Return
26.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.71%
1 Year Est. Return
+26.14%
3 Year Est. Return
+80.41%
5 Year Est. Return
+95.44%
10 Year Est. Return
+382.16%
AUM
$45B
AUM Growth
+$170M
(+0.38%)
Cap. Flow
-$2.88B
Cap. Flow
% of AUM
-6.41%
Top 10 Holdings %
Top 10 Hldgs %
16.72%
Holding
2,757
New
109
Increased
859
Reduced
1,347
Closed
244
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Emerging Markets Government Bond ETF
VWOB
|
+$222M |
| 2 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$210M |
| 3 |
Atlassian
TEAM
|
+$157M |
| 4 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$155M |
| 5 |
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$223M |
| 2 |
Microsoft
MSFT
|
+$192M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$176M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$132M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.76% |
| 2 | Healthcare | 11.58% |
| 3 | Financials | 10.07% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
1951
DELISTED
Apellis Pharmaceuticals
APLS
| $558K | ﹤0.01% |
10,796
-45,125
| -81% | -$2.39M |
|
1952
Sinclair Inc
SBGI
$992M
| $556K | ﹤0.01% |
35,824
-3,231
| -8% | -$57.5K |
|
|
SABRP
1953
DELISTED
Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock
SABRP
| $556K | ﹤0.01% |
+6,600
| New | +$507K |
|
1954
Sunrun
RUN
$2.34B
| $554K | ﹤0.01% |
23,088
-3,498
| -13% | -$93.4K |
|
1955
Viridian Therapeutics
VRDN
$2.09B
| $553K | ﹤0.01% |
+18,936
| New | +$436K |
|
1956
Ethan Allen Interiors
ETD
$570M
| $548K | ﹤0.01% |
20,749
-14,644
| -41% | -$378K |
|
1957
Healthcare Services Group
HCSG
$1.6B
| $548K | ﹤0.01% |
45,650
-17,500
| -28% | -$231K |
|
1958
Allegiant Air
ALGT
$2.64B
| $546K | ﹤0.01% |
8,022
+4,576
| +133% | +$334K |
|
|
LHCG
1959
DELISTED
LHC Group LLC
LHCG
| $545K | ﹤0.01% |
3,372
-2,214
| -40% | -$366K |
|
|
ETRN
1960
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $543K | ﹤0.01% |
81,086
+5,073
| +7% | +$39.3K |
|
1961
EverQuote
EVER
$892M
| $542K | ﹤0.01% |
36,786
+6,641
| +22% | +$62.4K |
|
1962
Construction Partners
ROAD
$5.84B
| $540K | ﹤0.01% |
20,249
-74,653
| -79% | -$2.14M |
|
1963
Bank of N.T. Butterfield & Son
NTB
$2.43B
| $534K | ﹤0.01% |
17,914
-6,859
| -28% | -$227K |
|
1964
Qfin Holdings
QFIN
$1.69B
| $532K | ﹤0.01% |
26,136
+4,943
| +23% | +$73.4K |
|
1965
Pathward Financial
CASH
$1.86B
| $532K | ﹤0.01% |
12,352
-937
| -7% | -$38.4K |
|
|
ICPT
1966
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $530K | ﹤0.01% |
+42,813
| New | +$606K |
|
1967
Lumen
LUMN
$6.57B
| $529K | ﹤0.01% |
101,269
-150,809
| -60% | -$927K |
|
|
VTYX
1968
DELISTED
Ventyx Biosciences
VTYX
| $527K | ﹤0.01% |
16,066
+4,452
| +38% | +$132K |
|
1969
UFP Technologies
UFPT
$1.97B
| $523K | ﹤0.01% |
4,434
-562
| -11% | -$59.9K |
|
|
BELFB
1970
Bel Fuse Inc Class B
BELFB
$3.87B
| $519K | ﹤0.01% |
15,762
+1,398
| +10% | +$45.6K |
|
1971
Protolabs
PRLB
$1.79B
| $517K | ﹤0.01% |
20,234
+6,880
| +52% | +$204K |
|
1972
Central Pacific Financial
CPF
$1.02B
| $512K | ﹤0.01% |
25,253
+2,381
| +10% | +$48.9K |
|
1973
eHealth
EHTH
$42.2M
| $509K | ﹤0.01% |
105,218
+533
| +0.5% | +$1.99K |
|
1974
Amylyx Pharmaceuticals
AMLX
$2.26B
| $509K | ﹤0.01% |
13,777
-49,897
| -78% | -$1.77M |
|
1975
First Financial Bankshares
FFIN
$5.04B
| $509K | ﹤0.01% |
14,790
-4,695
| -24% | -$178K |
|
Similar funds
SEI Investments's Q4 2022 Portfolio in Review
As of Q4 2022, SEI Investments held 2,757 positions worth $45B, up 0.38% from $44.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
SEI Investments withdrew a net $2.88B in Q4 2022, closing 244 positions and reducing 1,347 holdings. Its most notable exit was Abiomed Inc, an estimated $63.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, SEI Investments opened a new position in iShares Core MSCI International Developed Markets ETF worth $219M.
- SEI Investments's largest Q4 2022 buy was iShares Core MSCI International Developed Markets ETF: 3,906,565 shares worth $219M.
- SEI Investments added most to Vanguard Emerging Markets Government Bond ETF in Q4 2022, an estimated $222M increase.
- SEI Investments's biggest Q4 2022 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $223M.
- SEI Investments fully exited Abiomed Inc in Q4 2022, selling an estimated $63.5M.
- SEI Investments's ten largest holdings make up 17% of its $45B portfolio in Q4 2022.
- SEI Investments opened 109 new positions and closed 244 in Q4 2022.
- SEI Investments's portfolio value rose 0.38% quarter-over-quarter to $45B.
Based on SEI Investments's 13F filing for Q4 2022, filed 10 Feb 2023.